Search tips
ECCMID 2023
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
17 April 2023 - O1136
All-cause and attributable mortality in invasive candidiasis and/or Candidaemia with rezafungin and caspofungin treatment: outcomes from the ReSTORE trial
George Thompson, Oliver A Cornely, Alex Soriano, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
15 April 2023 - P2048
Rezafungin and caspofungin treatment response in candidaemia/invasive candidiasis by baseline Candida species: analysis of pooled Phase 2 and Phase 3 results
George Thompson, Oliver A Cornely, Alex Soriano, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
15 April 2023 - E0593
Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with Candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data
Oliver A Cornely, George R Thompson Rd, Alex Soriano, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
15 April 2023 - P2063
Treatment outcomes in candidaemia and/or invasive candidiasis among patients receiving rezafungin or caspofungin while the fungal culture was still positive
Oliver A. Cornely, George R Thompson Rd, Alex Soriano, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
15 April 2023 - P2061
Safety outcomes with rezafungin and caspofungin in the treatment of candidaemia and/or invasive candidiasis: phase 3 data from the ReSTORE trial
Alex Soriano, George R Thompson Rd, Oliver A Cornely, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
24 April 2022 - B0034
Patient-level meta-analysis of efficacy and safety from STRIVE and ReSTORE: randomised, double-blinded, multi-centre phase II and phase III trials of rezafungin in the treatment of candidaemia and/or invasive candidiasis
Alex Soriano, George R. Thompson, Oliver A Cornely, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M. Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F. Das, Taylor Sandison, Peter G. Pappas
22 April 2022 - O0106
Venetoclax and ibrutinib pharmacokinetics unaltered when co-administered with rezafungin
Shawn Flanagan, Voon Ong, Taylor Sandison
22 April 2022 - L0244
ReSTORE: efficacy and safety results of the phase III, noninferiority trial of rezafungin in the treatment of candidaemia and/or invasive candidiasis
George R. Thompson, Alex Soriano, Oliver A. Cornely, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M. Honore, Matteo Bassetti, John Pullman, Methee Chayakulkeeree, Cecilia Dignani, Anita F. Das, Taylor Sandison, Peter G. Pappas
09 July 2021 - 1677
Analysis of efficacy from STRIVE phase II trial of rezafungin treatment of candidaemia and/or invasive candidiasis: outcomes during initial days of treatment
Alex Soriano, A. Soriano (1), G.R. Thompson (2), J. Vazquez (3), P. Merino-Amador (4), A. Das (5), T. Sandison (5), P.G. Pappas (6)
08 July 2021 - 1672
Analysis of safety from STRIVE phase II Trial of rezafungin treatment of candidaemia and/or invasive candidiasis: assessment of adverse events and laboratory values
George R. Thompson, G.R. Thompson (1), A. Soriano (2), P.M. Honore (3), J.P. Horcajada (4), A. Das (5), T. Sandison (5), P.G. Pappas (6)
15 April 2019 - P2284
Outcomes in Europe from the STRIVE clinical trial of rezafungin treatment of candidaemia and/or invasive candidiasis
Taylor Sandison, Rolando Viani, Matteo Bassetti, Juan P. Horcajada, George Thompson
12 April 2019 - P0119
Phase II STRIVE clinical trial of rezafungin for the treatment of candidaemia and/or invasive candidiasis: results stratified by baseline renal function
Shawn Flanagan, Elizabeth A. Lakota, Christopher M. Rubino, Taylor Sandison, Peter George Pappas, Luis Ostrosky-Zeichner
09 April 2016 - PIP05
Cidara: New Hope for Serious Fungal Infections
Dirk Thye, Taylor Sandison
27 April 2015 - P1315
Efficacy of tedizolid in patients with complicated skin and soft tissue infections due to unknown causative pathogens
Taylor Sandison, Sandison, Taylor *; DeAnda, Carisa; Broyde, Natasha; Prokocimer, Philippe;
27 April 2015 - P1316
Efficacy and safety of tedizolid versus linezolid in patients with cellulitis/erysipelas: pooled results from the ESTABLISH clinical trials
Hina Patel, Sandison, Taylor; Patel, Hina *; DeAnda, Carisa; Broyde, Natasha; Prokocimer, Philippe;
26 April 2015 - O192
Efficacy and safety of tedizolid versus linezolid in patients with complicated skin and soft tissue infection after IV, IV/oral, or oral administration
Carisa De Anda, De Anda, Carisa *; Sandison, Taylor; Anuskiewicz, Steven; Prokocimer, Philippe;
24 April 2015 - EV0362
Does early clinical response predict late clinical success in patients with complicated skin and soft tissue infections (cSSTI)? Data from the ESTABLISH clinical trials
Anita Das, Das, Anita *; Corey, G. Ralph; Nathwani, Dilip; Sandison, Taylor; De Anda, Carisa; Prokocimer, Philippe;
Loading ...
FAQ
To access content in the eLibrary you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ECCMID where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.